Anghami Inc. - ANGHW

ANGHW Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
ANGHW	-22.2	0	16.7	122.9	8.0	75	-96.3	-88.3	-88.3	-88.3
S&P 500	-0.6	-0.5	2.3	7.3	12.1	32.1	27.0	90.7	191.4	33587.3

Compare ANGHW with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	ANGHW
name	Anghami Inc.
price	0.04
changes percentage	-22.22
change	-0.01
day low	0.04
day high	0.04
year high	0.04
year low	0.04
market cap	20354550
price avg 50	0
price avg 200	0
exchange	NASDAQ
volume	230
avg volume	0
open	0.04
previous close	0.04
eps	-185.24
pe	0
earnings announcement	None
shares outstanding	576625912
timestamp	2024-11-14 21:00:00

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 48.3%

Overall Quarterly Financial Health: 33.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001871983
revenue	41380440	48482015	-14.65
gross profit	10291898	9351493	10.06
gross profit ratio	0.25	0.19	28.94
research and development expenses	0	725577	-100.00
operating expenses	25557511	23906365	6.91
interest income	18959	15036	26.09
interest expense	268517	552751	-51.42
ebitda	-11524187	-55980563	79.41
ebitdaratio	-0.28	-0.23	-22.95
operating income	-14557807	-14554872	-0.02
operating income ratio	-0.35	-0.3	-17.19
net income	-15813351	-61221032	74.17
net income ratio	-0.38	-1.26	69.74
eps	-0.6	-2.35	74.47

Overall Score of Annual Income Statement

0.38 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 41 million in 2023 from 48 million in 2022 representing a change of -14.65%. This indicates a sales shrinking, which is a negative sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses decreased to 0 million in 2023 from 1 million in 2022 representing a change of -100.0%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 26 million in 2023 from 24 million in 2022 representing a change of 6.91%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to -12 million in 2023 from -56 million in 2022 representing a change of 79.41%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Net Income: Net income decreased to -16 million in 2023 from -61 million in 2022 representing a change of 74.17%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

• 📈 Positive Indicators

  Gross Profit: Gross Profit increased to 10 million in 2023 from 9 million in 2022 representing a change of 10.06%. This indicates a sales profitability growth, which is a positive sign for the company.

  Operating Income: Operating income increased to -15 million in 2023 from -15 million in 2022 representing a change of -0.02%. The increase in operating income indicates better operational performance and increased profitability.

  Earnings per Share (EPS): EPS increased to -0.6 in 2023 from -0.6 in 2022 representing a change of 74.47%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2023Q4	2023Q3	Q/Q change %
0001871983
revenue	11238364	11238364	0.00
gross profit	3621492	3621492	0.00
gross profit ratio	0.32	0.32	0.00
research and development expenses	193911	186870	3.77
operating expenses	5993745	5133571	16.76
interest income	67248	0	NaN
interest expense	0	0	NaN
ebitda	-1787727	-1675129	-6.72
ebitdaratio	-0.16	-0.15	-6.72
operating income	-2372253	-2446500	3.03
operating income ratio	-0.21	-0.22	3.03
net income	-1929619	-1929619	0.00
net income ratio	-0.17	-0.17	0.00
eps	-0.07	-0.07	1.64

Overall Score of Quarterly Income Statement

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Research and Development (R&D) Expenses: R&D Expenses increased to 0 million in 2023Q4 from 0 million in 2023Q3 representing a change of 3.77%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to -2 million in 2023Q4 from -2 million in 2023Q3 representing a change of -6.72%. The increase in EBITDA indicates improved operational efficiency and profitability.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 6 million in 2023Q4 from 5 million in 2023Q3 representing a change of 16.76%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  Operating Income: Operating income decreased to -2 million in 2023Q4 from -2 million in 2023Q3 representing a change of 3.03%. The decrease in operating income indicates worse operational performance and decreased profitability.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001871983
total assets	19464773	29634720	-34.32
total liabilities	33563040	36072352	-6.96
total equity	-14098267	-6437632	-119.00
cash and cash equivalents	6239080	3117087	100.16
short term investments	536	17947	-97.01
long term investments	619690	833495	-25.65
total current assets	15103897	18099173	-16.55
total non current assets	4360876	11535547	-62.20
total current liabilities	32300955	34704140	-6.92
total non current liabilities	1262085	1368212	-7.76
common stock	2971	2601	14.23
retained earnings	-138948686	-123135335	-12.84
total debt	170897	360800	-52.63

Overall Score of Annual Balance Sheet

0.5 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 19 million in 2023 from 30 million in 2022 representing a change of -34.32%. Suggesting a decrease in asset holdings.

  Total Equity: Total Equity decreased to -14 million in 2023 from -6 million in 2022 representing a change of -119.0%. This indicates a decrease in shareholders' equity.

  Short Term Investments: Short Term Investments decreased to 0 million in 2023 from 0 million in 2022 representing a change of -97.01%. This indicates a decrease in short-term investment holdings.

  Total Current Assets: Total Current Assets decreased to 15 million in 2023 from 18 million in 2022 representing a change of -16.55%. This indicates a worsen liquidity position.

  Retained Earnings: Retained Earnings decreased to -139 million in 2023 from -123 million in 2022 representing a change of -12.84%. This indicates an accumulated losses.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 34 million in 2023 from 36 million in 2022 representing a change of -6.96%. This indicates a decrease in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 6 million in 2023 from 3 million in 2022 representing a change of 100.16%. This indicates an increase in available liquid assets.

  Total Current Liabilities: Total Current Liabilities decreased to 32 million in 2023 from 35 million in 2022 representing a change of -6.92%. This indicates a lower short-term debt burden.

  Common Stock: Common Stock increased to 0 in 2023 from 0 in 2022 representing a change of 14.23%. This indicates an increase in ownership interest.

  Total Debt: Total Debt decreased to 0 million in 2023 from 0 million in 2022 representing a change of -52.63%. This indicates a reduction in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2023Q4	2023Q3	Q/Q change %
0001871983
total assets	19464773	19464773	0.00
total liabilities	33563040	33563040	0.00
total equity	-14098267	-14098267	0.00
cash and cash equivalents	6239080	6239080	0.00
short term investments	0	0	NaN
long term investments	619690	619690	0.00
total current assets	15103897	15103897	0.00
total non current assets	4360876	4360876	0.00
total current liabilities	32300955	32300955	0.00
total non current liabilities	1262085	1262085	0.00
common stock	2971	2971	0.00
retained earnings	-138948686	-138948686	0.00
total debt	170897	65832	159.60

Overall Score of Quarterly Balance Sheet

0.0 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Debt: Total Debt increased to 0 million in 2023Q4 from 0 million in 2023Q3 representing a change of 159.6%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001871983
net change in cash	3121993	2480791	25.85
operating cash flow	-3881791	84663	-4,684.99
free cash flow	-5119981	-11074061	53.77
capital expenditure	-1310678	-11158724	88.25
depreciation and amortization	3217940	3794785	-15.20
deferred income tax	654991	876928	-25.31
stock based compensation	-177001	564741	-131.34
accounts payables	-317879	22340143	-101.42
inventory	0	0	NaN
acquisitions net	0	-1418408	100.00
investments in property plant and equipment	-98534	-11158724	99.12
net cash used for investing activites	-1310678	-12577132	89.58
debt repayment	4766388	-11389678	141.85
common stock issued	0	30427800	-100.00
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	8310822	14973260	-44.50
cash at end of period	6239080	3113331	100.40
accounts receivables	5102620	-5632577	190.59
cash at beginning of period	3117087	632540	392.79

Overall Score of Annual Cashflow Statement

0.57 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 3 million in 2023 from 2 million in 2022 representing a change of 25.85%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Free Cash Flow: Free Cash Flow increased to -5 million in 2023 from -11 million in 2022 representing a change of 53.77%. This indicates an increase in cash generated after accounting for capital expenditures.

  Stock-Based Compensation: Stock-Based Compensation decreased to 0 million in 2023 from 1 million in 2022 representing a change of -131.34%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables decreased to 0 million in 2023 from 22 million in 2022 representing a change of -101.42%. This indicates that the company has reduced its outstanding obligations to its suppliers.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to -4 million in 2023 from 0 million in 2022 representing a change of -4684.99%. This indicates that the company generated less cash from its core business operations.

  Capital Expenditure: Capital Expenditure increased to -1 million in 2023 from -11 million in 2022 representing a change of 88.25%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Accounts Receivables: Accounts Receivables increased to 5 in 2023 from -6 million in 2022 representing a change of 190.59%. This suggests that the company is less capable of collecting payments from its customers.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023Q4	2023Q3	Q/Q change %
0001871983
operating cash flow	-1100168	-1100168	0.00
free cash flow	-1147379	-1147379	0.00
capital expenditure	-47211	-47211	0.00
depreciation and amortization	624917	431006	44.99
deferred income tax	0	0	NaN
stock based compensation	-14253	-14253	0.00
accounts receivables	1925495	1925495	0.00
accounts payables	0	0	NaN
inventory	0	0	NaN
acquisitions net	0	0	NaN
investments in property plant and equipment	-47211	-47211	0.00
net cash used for investing activites	-100195	-100195	0.00
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	3683994	3683994	0.00
net change in cash	2483631	2483631	0.00
cash at end of period	2483631	2483631	0.00
cash at beginning of period	0	0	NaN

Overall Score of Quarterly Cashflow Statement

0.5 out of 1

Detailed Analysis

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	1.57	1.86	-16.02
net income per share	-0.6	-2.35	74.59
operating cash flow per share	-0.15	0.0	-4,611.14
free cash flow per share	-0.19	-0.43	54.51
cash per share	0.24	0.12	95.82
book value per share	-0.53	-0.25	-115.47
tangible book value per share	-0.6	-0.56	-6.74
shareholders equity per share	-0.49	-0.2	-148.59
interest debt per share	0.01	0.02	-51.22
market cap	27488645.6	41609046.4	-33.94
enterprise value	21420462.6	38852759.4	-44.87
pe ratio	-1.74	-0.68	-155.77
price to sales ratio	0.66	0.86	-22.60
pocfratio	-7.08	491.47	-101.44
pfcf ratio	-5.37	-3.76	-42.89
pb ratio	-2.13	-8.13	73.85
ptb ratio	-2.13	-8.13	73.85
ev to sales	0.52	0.8	-35.41
enterprise value over ebitda	-1.86	-0.69	-167.81
ev to operating cash flow	-5.52	458.91	-101.20
ev to free cash flow	-4.18	-3.51	-19.25
earnings yield	-0.58	-1.47	60.90
free cash flow yield	-0.19	-0.27	30.02
debt to equity	-0.0	-0.0	22.07
debt to assets	0.0	0.0	199.75
net debt to ebitda	0.53	0.05	969.45
current ratio	0.47	0.52	-10.34
interest coverage	-54.22	-26.33	-105.89
income quality	0.25	-0.0	17,850.69
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0.39	0.38	2.66
research and ddevelopement to revenue	0	0.01	-100.00
intangibles to total assets	0.09	0.28	-66.88
capex to operating cash flow	-0.34	131.8	-100.26
capex to revenue	0.03	0.23	-86.24
capex to depreciation	0.41	2.94	-86.15
stock based compensation to revenue	-0.0	0.01	-136.72
graham number	2.57	3.23	-20.52
roic	1.18	2.89	-59.29
return on tangible assets	-0.89	-2.86	68.69
graham net net	-0.8	-0.89	10.01
working capital	-17197058	-16604967	-3.57
tangible asset value	-15883040	-14640787	-8.48
net current asset value	-18459143	-17973179	-2.70
invested capital	-13457256	-5904299	-127.92
average receivables	10677856.5	10861277.5	-1.69
average payables	11253020	9193594	22.40
average inventory	0	393800	-100.00
days sales outstanding	72.77	98.67	-26.24
days payables outstanding	119.69	114.84	4.22
days of inventory on hand	0	0	NaN
receivables turnover	5.02	3.7	35.58
payables turnover	3.05	3.18	-4.05
inventory turnover	0	0	NaN
roe	1.22	11.97	-89.78
capex per share	0.05	0.43	-88.44

• Neutral

  ROE: Return on Equity (ROE) decreased to 1.22 on 2023-12-31 from 11.97 on 2022-12-31, representing a change of -89.78%. However, ROE is >= 15%, suggesting that the company has been generating high returns for its shareholders still.

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to -1.74 on 2023-12-31 from -0.68 on 2022-12-31, representing a change of -155.77%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio decreased to 0.47 on 2023-12-31 from 0.52 on 2022-12-31, representing a change of -10.34%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Also, it's below 1, indicating potential liquidity issues.

• Positive

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to -0.00 on 2023-12-31 from -0.00 on 2022-12-31, representing a change of 22.07%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2023-12-31 Q4	2023-09-30 Q3	Q/Q change %
ANGHW
calendar year	2023	2023	NaN
revenue per share	0.42	0.43	-1.62
net income per share	-0.07	-0.07	1.62
operating cash flow per share	-0.04	-0.04	1.62
free cash flow per share	-0.04	-0.04	1.62
cash per share	0.23	0.24	-1.62
book value per share	-0.52	-0.53	1.62
tangible book value per share	-0.59	-0.6	1.62
shareholders equity per share	-0.48	-0.49	1.62
interest debt per share	0.0	0.0	-1.62
market cap	27934400	17994472.96	55.24
enterprise value	21866217	11821224.96	84.97
pe ratio	-3.62	-2.33	-55.24
price to sales ratio	2.49	1.6	55.24
pocfratio	-25.39	-16.36	-55.24
pfcf ratio	-24.35	-15.68	-55.24
pb ratio	-2.16	-1.39	-55.24
ptb ratio	-2.16	-1.39	-55.24
ev to sales	1.95	1.05	84.97
enterprise value over ebitda	-12.23	-7.06	-73.32
ev to operating cash flow	-19.88	-10.74	-84.97
ev to free cash flow	-19.06	-10.3	-84.97
earnings yield	-0.07	-0.11	35.58
free cash flow yield	-0.04	-0.06	35.58
debt to equity	-0.0	-0.0	0.00
debt to assets	0.0	0.0	0.00
net debt to ebitda	3.39	3.69	-7.89
current ratio	0.47	0.47	0.00
interest coverage	0	0	NaN
income quality	0.57	0.57	0.00
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0.42	0.42	0.00
research and ddevelopement to revenue	0.02	0.02	3.77
intangibles to total assets	0.09	0.09	0.00
capex to operating cash flow	-0.04	-0.04	0.00
capex to revenue	0.0	0.0	0.00
capex to depreciation	0.08	0.11	-31.03
stock based compensation to revenue	-0.0	-0.0	0.00
graham number	0.88	0.9	-1.62
roic	0.2	0.21	-3.03
return on tangible assets	-0.11	-0.11	0.00
graham net net	-0.77	-0.86	9.99
working capital	-17197058	-17197058	0.00
tangible asset value	-15883040	-15883040	0.00
net current asset value	-18459143	-18459143	0.00
invested capital	-13457256	-13457256	0.00
average receivables	7583991.5	6322502	19.95
average payables	10194121	19157687.5	-46.79
average inventory	0.5	1	-50.00
days sales outstanding	70.99	50.48	40.64
days payables outstanding	120.45	120.45	0.00
days of inventory on hand	0	0.0	-100.00
receivables turnover	1.27	1.78	-28.90
payables turnover	0.75	0.75	0.00
inventory turnover	0	7616872	-100.00
roe	0.15	0.15	0.00
capex per share	0.0	0.0	-1.62

• Neutral

  ROE: Return on Equity (ROE) decreased to 0.15 on 2023-12-31 Q4 from 0.15 on 2023-09-30 Q3, representing a change of 0.00%. However, ROE is >= 15%, suggesting that the company has been generating high returns for its shareholders still.

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to -3.62 on 2023-12-31 Q4 from -2.33 on 2023-09-30 Q3, representing a change of -55.24%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio decreased to 0.47 on 2023-12-31 Q4 from 0.47 on 2023-09-30 Q3, representing a change of 0.00%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Also, it's below 1, indicating potential liquidity issues.

• Positive

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to -0.00 on 2023-12-31 Q4 from -0.00 on 2023-09-30 Q3, representing a change of 0.00%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None